Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: Relevance of glycated collagen products versus HbA(1c) as markers of diabetic complications

Diabetes

Volumn 48, Issue 4, 1999, Pages 870-880

  Monnier, Vincent M ^a,e   Bautista, Oliver ^d   Kenny, David ^d   Sell, David R ^a   Fogarty, John ^a   Dahms, William ^b   Cleary, Patricia A ^d   Lachin, John ^d   Genuth, Saul ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Mt Sinai Medical Center Cleveland   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN; FUROSINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; N (CARBOXYMETHYL)LYSINE; PENTOSIDINE; PEPSIN A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CROSS LINKING; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; GLYCATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SOLUBILITY;

EID: 0032997958     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.4.870     Document Type: Article

References (32)

1. Nathan DM, Singer DE, Hurxthal K, Goodson JD: The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 310:341-346, 1984
2. The Diabetes Control and Complications Trial (DCCT): The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Vlassara H, Bucala R, Striker L: Pathogenic effects of advanced glycosylation: biochemical, biological, and clinical implications for diabetes and aging. Lab Invest 70:138-151, 1994
4. Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR: Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence. N Engl J Med 314:403-408, 1986
5. Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM: Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 41:1286-1292, 1992
6. Beisswenger PJ, Moore LL, Curphey TJ: Relationship between glycemic control and collagen-linked advanced glycosylation end products in type I diabetes. Diabetes Care 16:689-694, 1993
7. Beisswenger P, Makita Z, Curphey TJ, Moore LL, Jean S, Brinck-Johnsen T, Bucala R, Vlassara H: Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44:824-829, 1995
8. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR, Baynes JW, Lyons TJ: Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470-2478, 1993
9. Lyons TJ, Bailie KE, Dyer DG, Dunn JA, Baynes JW: Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest 87:1910-1915, 1991
10. Salmela Pl, Oikarinen AI, Ukkola O, Karjalainen A, Linnaluoto M, Puukka R, Ryhanen L: Improved metabolic control in patients with non-insulin-dependent diabetes mellitus is associated with a slower accumulation of glycation products in collagen. Eur J Clin Inivst 25:494-500, 1995
11. Vishwanath V, Frank KE, Elmets CA, Dauchot PJ, Monnier VM: Glycation of skin collagen in type I diabetes mellitus: correlation with long-term complications. Diabetes 35:916-921, 1986
12. Buckingham B, Reiser KM: Relationship between the content of lysyl oxidase-dependent cross-links in skin collagen, nonenzymatic glycosylation, and long-term complications in type I diabetes mellitus. J Clin Invest 86:1046-1054, 1990
13. 1c) to the risk of development and progression in the Diabetes Control and Complications Trial. Diabetes 44:978-983, 1995
14. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCance DR, Baynes JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463-2469, 1993
15. Monnier VM, Kohn RR, Cerami A: Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci U S A 81:583-587, 1984
16. Resmini P, Pellegrino L, Battelli G: Accurate quantification of furosine in milk and dairy products by a direct HPLC method. Ital J Food Sci 3:173-183, 1990
17. Wu YC, Monnier VM, Friedlander MA: Reliable determination of furosine in human serum and dialysate proteins by high-performance liquid chromatography. J Chrom B667:328-332, 1995
18. Glomb MA, Monnier VM: Mechanism of protein modification by glyoxal and glycolaldehyde reactive intermediates of the Maillard reaction. J Biol Chem 270:10017-10026, 1995
19. The DCCT Research Group: The Diabetes Control and Complications Trial (DCCT). Diabetes 35:530-545, 1986
20. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 113:36-51, 1995
21. The Diabetes Control and Complications Trial Research Group: Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology 102:647-661, 1995
22. The DCCT Research Group: Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. Clin Chem 33:2207-2271, 1987
23. Snedecor GW, Cochran WC: Statistical Methods. Ames, IA, Iowa State University Press, 1967
24. Searle SR: Linear Models for Unbalanced Data. New York, Wiley, 1987
25. Neter J, Wasserman W: Applied Linear Statistical Models. Homewood, IL, Irwin, 1974
26. Morrison DF: Multivariate Statistical Methods. New York, McGraw-Hill, 1976
27. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, Wiley, 1989
28. Acharya AS, Roy RP, Dorai B: Aldimine to ketoamine isomerization (Amadori rearrangement) potential at the individual nonenzymic glycation sites of hemoglobin A: preferential inhibition of glycation by nucleophiles at sites of low isomerization potential. J Prot Chem 10:345-357, 1991
29. ε-(carboxvmethyl)-lysine is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271:9982-9986, 1996
30. Klein WR, Klein BEK, Moss SE, Davis MD, DeMets DL: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260:2864-2871, 1988
31. Berg TJ, Bangstad H-J, Torjesen PA, Osterby R, Bucala R, Hanssen KF: Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus. Metabolism 46:661-365, 1997
32. Brownlee M: Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15:1835-1843, 1992